163 related articles for article (PubMed ID: 19247814)
1. Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer.
Ren T; Jiang B; Xing X; Dong B; Peng L; Meng L; Xu H; Shou C
Pathol Oncol Res; 2009 Dec; 15(4):555-60. PubMed ID: 19247814
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.
Wang L; Peng L; Dong B; Kong L; Meng L; Yan L; Xie Y; Shou C
Ann Oncol; 2006 Oct; 17(10):1517-22. PubMed ID: 16873432
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma.
Reich R; Hadar S; Davidson B
Int J Mol Sci; 2011 Feb; 12(2):1133-45. PubMed ID: 21541048
[TBL] [Abstract][Full Text] [Related]
4. A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer.
Liu C; Zhong W; Xia L; Fang C; Liu H; Liu X
Medicine (Baltimore); 2021 Apr; 100(17):e25658. PubMed ID: 33907129
[TBL] [Abstract][Full Text] [Related]
5. PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
Liu H; Al-aidaroos AQ; Wang H; Guo K; Li J; Zhang HF; Zeng Q
BMC Cancer; 2013 Feb; 13():80. PubMed ID: 23418787
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.
Bilici A; Ustaalioglu BB; Yavuzer D; Seker M; Mayadagli A; Gumus M
Dig Dis Sci; 2012 Jun; 57(6):1568-75. PubMed ID: 22331511
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal and Phosphatase of Regenerating Liver-3 Status in Circulating Tumor Cells May Serve as a Crucial Prognostic Marker for Assessing Relapse or Metastasis in Postoperative Patients With Colorectal Cancer.
Su P; Lai W; Liu L; Zeng Y; Xu H; Lan Q; Chu Z; Chu Z
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00265. PubMed ID: 33512811
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.
Hao RT; Zhang XH; Pan YF; Liu HG; Xiang YQ; Wan L; Wu XL
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1349-57. PubMed ID: 20140626
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer.
Ustaalioglu BB; Bilici A; Barisik NO; Aliustaoglu M; Vardar FA; Yilmaz BE; Seker M; Gumus M
Clin Transl Oncol; 2012 Dec; 14(12):911-22. PubMed ID: 22855168
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
Xu Y; Zhu M; Zhang S; Liu H; Li T; Qin C
Pathol Oncol Res; 2010 Jun; 16(2):169-75. PubMed ID: 19757198
[TBL] [Abstract][Full Text] [Related]
11. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer.
Dai N; Lu AP; Shou CC; Li JY
World J Gastroenterol; 2009 Mar; 15(12):1499-505. PubMed ID: 19322925
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Zhou J; Wang S; Lu J; Li J; Ding Y
Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
[TBL] [Abstract][Full Text] [Related]
13. Combined expression of metastasis related markers Naa10p, SNCG and PRL-3 and its prognostic value in breast cancer patients.
Min L; Ma RL; Yuan H; Liu CY; Dong B; Zhang C; Zeng Y; Wang L; Guo JP; Qu LK; Shou CC
Asian Pac J Cancer Prev; 2015; 16(7):2819-26. PubMed ID: 25854368
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of PRL-3 overexpression in early stages of colonic cancer.
Xing X; Peng L; Qu L; Ren T; Dong B; Su X; Shou C
Histopathology; 2009 Feb; 54(3):309-18. PubMed ID: 19236507
[TBL] [Abstract][Full Text] [Related]
15. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.
Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J
J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843
[TBL] [Abstract][Full Text] [Related]
16. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.
Xu Y; Wang C; Zhang Y; Jia L; Huang J
Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056
[TBL] [Abstract][Full Text] [Related]
18. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
[No Abstract] [Full Text] [Related]
19. Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.
Andersen S; Richardsen E; Rakaee M; Bertilsson H; Bremnes R; Børset M; Busund LT; Slørdahl T
PLoS One; 2017; 12(11):e0189000. PubMed ID: 29190795
[TBL] [Abstract][Full Text] [Related]
20. Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases.
Guzińska-Ustymowicz K; Kiśluk J; Terlikowski SJ; Pryczynicz A; Niewiarowska K; Ustymowicz M; Hawryluk M; Południewski M; Kemona A
Adv Med Sci; 2013; 58(2):221-6. PubMed ID: 23729584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
